| Company | Offer Price Band (₹) | Open Date | Close Date |
|---|
| Company | LTP (₹) | Listing Price (₹) | Issue Price (₹) | Date of Listing |
|---|
| Company | *Ratio (GIVE:HELD) | Ex Date | Record Date |
|---|
[*]: This ratio indicates how many bonus shares you will receive for each share you already hold in your Demat account.
The IPO comprises a fresh issue of 1 crore equity shares and an offer for sale of 25 lakh equity shares
Ahead of its IPO, CMPDI raised ₹470 crore from anchor investors, allotting 27.3 million shares at ₹163-₹172 each on March 19.
GSP Crop Science set to debut on the bourses on Tuesday, March 24, while Central Mine Planning & Design Institute's IPO will close for bidding on the same day
Amir Chand Jagdsh Kumar has set the price band for its IPO in the range of ₹201 to ₹212 per share
Existing investors State Bank of India and Amundi will sell 203.7 million shares through the "offer for sale" route. SBI Funds will not issue new shares in the IPO
The unlisted shares of Central Mine Planning were trading almost flat at ₹175, up ₹3 or 1.7 per cent compared to the issue price of ₹172 per share, according to sources tracking unofficial markets
As per the circular, the state-owned firm allotted 2.73 crore equity shares to 22 funds at ₹172 per piece, aggregating the transaction size to ₹469.74 crore
Powerica and Sai Parenteral IPOs will open on March 24 amid mixed investor sentiment, while GSP Crop Science's ₹400-crore issue saw 1.61 times subscription
The IPO will be executed as a so-called "offer for sale" in India, three of the sources said, where only existing shareholders sell their shareholding to public
The unlisted shares of Central Mine Planning were trading at ₹183 in the grey market, commanding a premium of ₹11 or 6.4 per cent from the upper end price of ₹172
Based on an expected deal size of about $2.5 billion, the total fee pool could be about $16.25 million, with the bulk likely to be shared among the six lead banks
Sai Parenteral's ₹409 crore IPO comprises a fresh issue of 7.3 million shares worth up to ₹285 crore and an OFS of 3.2 million shares worth up to ₹124 crore
The microfinance lender is targeting an AUM of Rs 9,000 crore in FY27
Sai Parenteral's IPO comprises a fresh issue of ₹285 crore and an offer for sale (OFS) of 3.2 million equity shares
Despite the potential to overtake HMIL's IPO in size, the fees paid to investment bankers are likely to be lower than the record ₹493 crore - about 1.77% of the issue size - in the automaker's listing
PhonePe has temporarily deferred its IPO plans citing the West Asia conflict and volatile markets, though the company says it remains committed to pursuing a public listing in India
The development comes at a time when Indian equity markets are under pressure due to the ongoing conflict in West Asia
The public issue is being offered at a price band of $10-$10.5 per share, in a fully dollar-denominated offering, and is accessible to eligible global investors
GSP Crop Science has set the price band for the issue in the range of ₹304 to ₹320 per share, with a lot size of 46 shares
The rules state that at least 2.5 per cent of each class of securities must be offered to the public at the time of listing, irrespective of the post-issue threshold